Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
247.6 EUR | +0.81% | -.--% | -.--% |
06-07 | Roche: efficacy of Evrysdi in spinal muscular atrophy | CF |
06-07 | Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children | MT |
- Stock Market
- Equities
- ROG Stock
- RHO Stock
- News Roche Holding AG
- Other languages